GlassScriptPhysician profile
Christopher James Lincoski
NPI 1265494769
$3,181.77
in general payments reported to CMS, 2019-2025
14 companies · $236 in 2025
The $236 reported for 2025 was less than what a typical Surgery of The Hand (Surgery) provider received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,911 · 2020: $72.24 · 2021: $74.13 · 2022: $207 · 2023: $267 · 2024: $414 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $917.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trimed, INC. | $1,857.02 | 2019-2024 | |
| Endo Pharmaceuticals INC. | $388.85 | 2019-2024 | Xiaflex |
| Skeletal Dynamics INC | $263.40 | 2023-2024 | Align, Implate, Ijs |
| Endo USA, INC. | $148.84 | 2024-2025 | Xiaflex |
| Acumed LLC | $135.13 | 2024 | Inframe Implant, Arcphix System, Innate Implant |
| Bioventus LLC | $102.77 | 2022-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Axogen | $92.58 | 2020-2025 | |
| Arthrosurface Incorporated | $76.99 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $40.91 | 2025 | |
| Stryker Corporation | $24.51 | 2023 | Chromophare F300 |
| Baudax Bio INC. | $19.27 | 2020 | |
| Pfizer INC. | $16.58 | 2019 | |
| Integra Lifesciences Corporation | $14.92 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Lincoski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.